LGALS3 and cancer: Numerous mechanisms underlie cancer chemoresistance (Rebucci and Michiels, 2013), but it appears that galectin-3 which is overexpressed in numerous tumor types, suppresses cell apoptosis and hence, decreases sensitivity of cancer cells to chemotherapeutic drugs (Glinsky and Raz, 2009).